Amoy Diagnostics Co., Ltd. (SHE:300685)
China · Delayed Price · Currency is CNY 19.41
+0.19 (0.99%)
May 19, 2026, 10:25 AM CST
Amoy Diagnostics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 355.94 | 361.26 | 254.86 | 261.48 | 263.74 | 239.57 |
Depreciation & Amortization | 48.66 | 48.66 | 55.88 | 56.55 | 52.27 | 38.91 |
Other Amortization | 9.93 | 9.93 | 3.23 | 2.62 | 0.96 | 0.76 |
Loss (Gain) From Sale of Assets | -0.49 | -0.49 | 1.06 | 0.96 | -94.58 | 1.96 |
Asset Writedown & Restructuring Costs | 33.95 | 33.95 | 38.43 | 18.88 | 9.65 | 11.1 |
Loss (Gain) From Sale of Investments | -14.69 | -14.69 | 0.49 | 2 | -1.98 | -8.31 |
Other Operating Activities | 18.3 | 8.95 | 1.91 | -6.86 | -22.13 | 9.31 |
Change in Accounts Receivable | -105.04 | -105.04 | -38.36 | -10.57 | 25.91 | -132.32 |
Change in Inventory | -2.97 | -2.97 | -5.58 | 4.06 | -0.57 | -10.84 |
Change in Accounts Payable | 27.69 | 27.69 | 34.73 | -31 | -97.96 | 19.16 |
Operating Cash Flow | 368.86 | 364.82 | 341.85 | 298.72 | 149.04 | 168.16 |
Operating Cash Flow Growth | 1.19% | 6.72% | 14.44% | 100.43% | -11.37% | -23.80% |
Capital Expenditures | -72.12 | -70.23 | -40.21 | -44.87 | -78.29 | -74.55 |
Sale of Property, Plant & Equipment | 1.84 | 1.84 | 0.22 | 12.5 | 51.93 | 3.3 |
Investment in Securities | -242.46 | -180.06 | -47.6 | -306.56 | -23.47 | -177.64 |
Other Investing Activities | 16.86 | 16.55 | 14.29 | 6.93 | 9.62 | 6.22 |
Investing Cash Flow | -295.88 | -231.9 | -73.3 | -331.99 | -40.2 | -242.67 |
Long-Term Debt Issued | - | 101 | - | 5 | 50 | - |
Total Debt Issued | 195 | 101 | - | 5 | 50 | - |
Long-Term Debt Repaid | - | -50.45 | -11.15 | -5.86 | -4.23 | -2.41 |
Total Debt Repaid | -51.4 | -50.45 | -11.15 | -5.86 | -4.23 | -2.41 |
Net Debt Issued (Repaid) | 143.59 | 50.54 | -11.15 | -0.86 | 45.77 | -2.41 |
Issuance of Common Stock | - | - | - | 51.66 | - | - |
Repurchase of Common Stock | -33.98 | -33.98 | -88.03 | -12.04 | -100.71 | -4.38 |
Common Dividends Paid | -119.17 | -118.95 | -60.59 | -56.17 | -51.47 | -55.43 |
Other Financing Activities | -66.3 | 0.68 | 0.13 | -0.64 | -14.17 | 15.9 |
Financing Cash Flow | -75.86 | -101.7 | -159.64 | -18.04 | -120.58 | -46.32 |
Foreign Exchange Rate Adjustments | -20.69 | -5.14 | 5.48 | 8.81 | 24.59 | -9.99 |
Net Cash Flow | -23.57 | 26.08 | 114.38 | -42.51 | 12.85 | -130.82 |
Free Cash Flow | 296.73 | 294.6 | 301.64 | 253.85 | 70.75 | 93.61 |
Free Cash Flow Growth | -7.67% | -2.33% | 18.82% | 258.79% | -24.42% | -42.50% |
Free Cash Flow Margin | 25.02% | 24.60% | 27.20% | 24.33% | 8.40% | 10.21% |
Free Cash Flow Per Share | 0.74 | 0.73 | 0.76 | 0.64 | 0.18 | 0.23 |
Cash Income Tax Paid | 150.96 | 150.96 | 83.87 | 49.88 | 57.92 | 51.18 |
Levered Free Cash Flow | 143.73 | 139.4 | 178.63 | 199.87 | -33.07 | -25.71 |
Unlevered Free Cash Flow | 144.98 | 140.61 | 179.47 | 200.62 | -32.45 | -25.47 |
Change in Working Capital | -82.75 | -82.75 | -14.02 | -36.9 | -58.91 | -125.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.